Computational modeling of lung deposition of inhaled particles in chronic obstructive pulmonary disease (COPD) patients: identification of gaps in knowledge and data

DOI Web Site 1 Citations

Koustav Ganguly

Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;
Ulrika Carlander

Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;
Estella DG Garessus

Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;
Markus Fridén

Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden;
Ulf G Eriksson

Early Clinical Development, IMED Biotech Unit, Quantitative Clinical Pharmacology, AstraZeneca, Gothenburg, Sweden;
Ulrika Tehler

Pharmaceutical Sciences, IMED Biotech Unit, Early Product Development, AstraZeneca, Gothenburg, Sweden
Gunnar Johanson

Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;

Journal

Critical Reviews in Toxicology

Critical Reviews in Toxicology 49 (2), 160-173, 2019-02-07

Informa UK Limited

Back to top